Stephens Inc’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Sell |
19,545
-114
| -0.6% | -$7.94K | 0.02% | 586 |
|
|
2025
Q4 | $1.3M | Sell |
19,659
-1,139
| -5% | -$73.6K | 0.02% | 574 |
|
|
2025
Q3 | $1.4M | Sell |
20,798
-2,890
| -12% | -$229K | 0.02% | 559 |
|
|
2025
Q2 | $2.07M | Buy |
23,688
+1,942
| +9% | +$152K | 0.03% | 456 |
|
|
2025
Q1 | $1.49M | Buy |
21,746
+392
| +2% | +$32K | 0.02% | 535 |
|
|
2024
Q4 | $1.66M | Sell |
21,354
-1,604
| -7% | -$119K | 0.02% | 484 |
|
|
2024
Q3 | $1.54M | Buy |
22,958
+1,220
| +6% | +$100K | 0.02% | 502 |
|
|
2024
Q2 | $2.46M | Sell |
21,738
-1,731
| -7% | -$219K | 0.04% | 384 |
|
|
2024
Q1 | $3.26M | Buy |
23,469
+770
| +3% | +$96.8K | 0.05% | 321 |
|
|
2023
Q4 | $2.82M | Sell |
22,699
-8,348
| -27% | -$853K | 0.05% | 323 |
|
|
2023
Q3 | $2.9M | Sell |
31,047
-12,185
| -28% | -$1.37M | 0.06% | 303 |
|
|
2023
Q2 | $5.56M | Buy |
43,232
+21,538
| +99% | +$2.6M | 0.1% | 216 |
|
|
2023
Q1 | $2.52M | Sell |
21,694
-568
| -3% | -$63.6K | 0.05% | 334 |
|
|
2022
Q4 | $2.52M | Sell |
22,262
-1,152
| -5% | -$126K | 0.05% | 322 |
|
|
2022
Q3 | $1.89M | Buy |
23,414
+1,556
| +7% | +$132K | 0.04% | 378 |
|
|
2022
Q2 | $1.63M | Sell |
21,858
-298
| -1% | -$27.2K | 0.03% | 425 |
|
|
2022
Q1 | $2.83M | Buy |
22,156
+940
| +4% | +$103K | 0.05% | 357 |
|
|
2021
Q4 | $2.85M | Buy |
21,216
+208
| +1% | +$29.9K | 0.04% | 379 |
|
|
2021
Q3 | $2.87M | Buy |
21,008
+172
| +0.8% | +$21.7K | 0.04% | 381 |
|
|
2021
Q2 | $2.22M | Buy |
20,836
+5,112
| +33% | +$491K | 0.03% | 455 |
|
|
2021
Q1 | $1.41M | Buy |
15,724
+1,424
| +10% | +$134K | 0.02% | 534 |
|
|
2020
Q4 | $1.32M | Buy |
14,300
+6,144
| +75% | +$549K | 0.02% | 528 |
|
|
2020
Q3 | $841K | Buy |
8,156
+1,668
| +26% | +$174K | 0.02% | 594 |
|
|
2020
Q2 | $658K | Sell |
6,488
-1,872
| -22% | -$167K | 0.01% | 631 |
|
|
2020
Q1 | $563K | Sell |
8,360
-1,008
| -11% | -$62.7K | 0.02% | 609 |
|
|
2019
Q4 | $512K | Sell |
9,368
-7,656
| -45% | -$363K | 0.01% | 717 |
|
|
2019
Q3 | $635K | Sell |
17,024
-2,464
| -13% | -$95.7K | 0.01% | 687 |
|
|
2019
Q2 | $730K | Buy |
19,488
+1,320
| +7% | +$41.5K | 0.02% | 653 |
|
|
2019
Q1 | $541K | Sell |
18,168
-868
| -5% | -$30.5K | 0.01% | 738 |
|
|
2018
Q4 | $570K | Sell |
19,036
-1,328
| -7% | -$42.1K | 0.02% | 665 |
|
|
2018
Q3 | $728K | Buy |
+20,364
| New | +$631K | 0.02% | 676 |
|
|
2017
Q3 | – | Sell |
-28,540
| Closed | -$522K | – | 750 |
|
|
2017
Q2 | $522K | Buy |
28,540
+12,580
| +79% | +$232K | 0.02% | 559 |
|
|
2017
Q1 | $338K | Sell |
15,960
-15,180
| -49% | -$296K | 0.01% | 640 |
|
|
2016
Q4 | $465K | Buy |
31,140
+4,516
| +17% | +$80K | 0.02% | 505 |
|
|
2016
Q3 | $583K | Sell |
26,624
-86,084
| -76% | -$1.92M | 0.03% | 474 |
|
|
2016
Q2 | $2.23M | Buy |
112,708
+80,856
| +254% | +$1.38M | 0.1% | 227 |
|
|
2016
Q1 | $541K | Buy |
31,852
+14,676
| +85% | +$245K | 0.03% | 449 |
|
|
2015
Q4 | $352K | Buy |
17,176
+12,120
| +240% | +$252K | 0.02% | 505 |
|
|
2015
Q3 | $109K | Sell |
5,056
-6,560
| -56% | -$146K | 0.01% | 687 |
|
|
2015
Q2 | $232K | Sell |
11,616
-2,284
| -16% | -$40.1K | 0.01% | 669 |
|
|
2015
Q1 | $217K | Buy |
+13,900
| New | +$210K | 0.01% | 693 |
|
Other funds holding DXCM
VCM
VPM
Stephens Inc's DXCM Position: Q1 2026 in Review
Stephens Inc reduced its DexCom (DXCM) stake by 0.58% in Q1 2026, selling an estimated $7.94K and leaving 19,545 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #586.
Stephens Inc first reported a position in DXCM in Q1 2015 and has held it in 41 quarters since. The position peaked at $5.56M in Q2 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Stephens Inc held 19,545 shares of DexCom worth $1.23M as of Q1 2026.
- Stephens Inc sold 114 DexCom shares in Q1 2026, an estimated $7.94K.
- DexCom made up 0.02% of Stephens Inc's portfolio in Q1 2026, its #586 holding.
- Stephens Inc first reported a position in DexCom in Q1 2015 and has held it in 41 quarters since.
- Stephens Inc's DexCom position peaked at $5.56M in Q2 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.